Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
94K
-
Shares change
-
+24.9K
-
Total reported value, excl. options
-
$194K
-
Value change
-
+$46.2K
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$2.05
Significant Holders of ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) as of Q1 2024
11 filings reported holding ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADS as of Q1 2024.
ALTERITY THERAPEUTICS LTD - SPONSORED ADS (ATHE) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94K shares
.
Largest 10 shareholders include MORGAN STANLEY (52K shares), CITADEL ADVISORS LLC (18.3K shares), XTX Topco Ltd (17.4K shares), Twin Lakes Capital Management, LLC (5.93K shares), Providence Capital Advisors, LLC (200 shares), OSAIC HOLDINGS, INC. (81 shares), Sugarloaf Wealth Management, LLC (33 shares), CoreCap Advisors, LLC (21 shares), Steward Partners Investment Advisory, LLC (6 shares), and UBS Group AG (2 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.